LifeCell Corp (NASDAQ:LIFC.DL)
CAPS Rating:
The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.
The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.